ormalvi

Generic: dichlorphenamide

Labeler: cycle pharmaceuticals ltd.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ormalvi
Generic Name dichlorphenamide
Labeler cycle pharmaceuticals ltd.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

dichlorphenamide 50 mg/1

Manufacturer
Cycle Pharmaceuticals Ltd.

Identifiers & Regulatory

Product NDC 70709-085
Product ID 70709-085_8716de8d-f4b6-4192-892c-cb22b511257c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA215924
Listing Expiration 2026-12-31
Marketing Start 2024-03-15

Pharmacologic Class

Established (EPC)
carbonic anhydrase inhibitor [epc]
Mechanism of Action
carbonic anhydrase inhibitors [moa]
Chemical Structure
sulfonamides [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70709085
Hyphenated Format 70709-085

Supplemental Identifiers

RxCUI
197594 2677447
UPC
0370709085104
UNII
VVJ6673MHY
NUI
N0000175517 N0000000235 M0020790

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ormalvi (source: ndc)
Generic Name dichlorphenamide (source: ndc)
Application Number ANDA215924 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (70709-085-10)
source: ndc

Packages (1)

70709-085-10 100 TABLET in 1 BOTTLE (70709-085-10)

Ingredients (1)

dichlorphenamide (50 mg/1)

Linked Drug Pages (1)

ORMALVI ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "8716de8d-f4b6-4192-892c-cb22b511257c", "openfda": {"nui": ["N0000175517", "N0000000235", "M0020790"], "upc": ["0370709085104"], "unii": ["VVJ6673MHY"], "rxcui": ["197594", "2677447"], "spl_set_id": ["3989e220-6502-449b-be39-e2689acce08c"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_epc": ["Carbonic Anhydrase Inhibitor [EPC]"], "pharm_class_moa": ["Carbonic Anhydrase Inhibitors [MoA]"], "manufacturer_name": ["Cycle Pharmaceuticals Ltd."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (70709-085-10)", "package_ndc": "70709-085-10", "marketing_start_date": "20240315"}], "brand_name": "ORMALVI", "product_id": "70709-085_8716de8d-f4b6-4192-892c-cb22b511257c", "dosage_form": "TABLET", "pharm_class": ["Carbonic Anhydrase Inhibitor [EPC]", "Carbonic Anhydrase Inhibitors [MoA]", "Sulfonamides [CS]"], "product_ndc": "70709-085", "generic_name": "Dichlorphenamide", "labeler_name": "Cycle Pharmaceuticals Ltd.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ORMALVI", "active_ingredients": [{"name": "DICHLORPHENAMIDE", "strength": "50 mg/1"}], "application_number": "ANDA215924", "marketing_category": "ANDA", "marketing_start_date": "20240315", "listing_expiration_date": "20261231"}